Creatinine Clearance (Cockcroft-Gault Equation)
Estimates creatinine clearance for medicine dosing.
Estimates creatinine clearance for medicine dosing.
Estimates pre-test probability of pulmonary embolism in adults.
Estimates thromboembolic stroke risk in adults with non-valvular atrial fibrillation.
Helps exclude PE in haemodynamically stable, low-risk adults.
Estimates pre-test probability of lower-limb deep vein thrombosis.
Stratifies 6-week risk of major adverse cardiac events in adults with chest pain.
Estimates 1-year major bleeding risk and identifies modifiable bleeding risks in atrial fibrillation.
Assesses level of consciousness using eye opening, verbal response and motor response.
Flags adults with suspected infection outside intensive care who have a higher risk of in-hospital death or an ICU stay of 3 days or longer.
Assesses organ dysfunction severity in critically ill adults.
Estimates 30-day mortality risk in adults with community-acquired pneumonia.
Estimates the likelihood of group A streptococcal pharyngitis.
Estimates adult eGFR from standardised serum creatinine and/or cystatin C using race-free CKD-EPI equations.
Estimates albumin-adjusted total calcium in adults when ionised calcium is unavailable.
Calculates the serum anion gap and albumin-corrected anion gap from routine chemistry values.
Estimates 90-day mortality risk in patients aged 12 years and over with cirrhosis.
Classifies severity of chronic liver disease, mainly cirrhosis, and estimates short-term mortality.
Calculates adult BMI category and Mosteller body surface area from height and weight.
Calculates adult Devine ideal body weight and 0.4-factor adjusted body weight for selected dosing contexts.
Estimates 24-hour and hourly maintenance intravenous fluid requirements from body weight using the Holliday–Segar method.
Estimates the ACI modified Parkland starting fluid requirement for major burns.
Identifies acute ankle or midfoot injuries that meet criteria for radiography.
Assesses newborn condition at 1 and 5 minutes after birth.
Screens for and monitors depression severity over the past 2 weeks.
Screens for and grades generalised anxiety symptoms in adults over the past 2 weeks.
Screens for unhealthy alcohol use over the past year.
Rules out pulmonary embolism using three clinical criteria and a variable D-dimer threshold.
Estimates 14-day risk of death, MI, or urgent revascularisation in UA/NSTEMI.
Estimates 24-hour vancomycin exposure in adults receiving intermittent IV dosing.
Assesses croup severity.